- The antibody immunoglobulin E, thought to play a key role in thedevelopment of allergy-induced asthma, may not be required for the expression of the disease in mice, say researchers from four institutions in the USA. A mold, known to cause asthma in humans, produced inflammation of the airways in both normal mice and in genetically-altered IgE-deficient mice. In addition, without allergan exposure, the baseline level of bronchial muscle contraction was higher in IgE-deficient mice than in normal mice.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze